Medicine price awareness in chronic patients in Belgium

The World Bank Group, 2014 Reeves, 2014, The political economy of austerity and healthcare: cross-national analysis of expenditure changes in 27 European nations 1995–2011, Health Policy, 115, 1, 10.1016/j.healthpol.2013.11.008 De Graeve, 2006, 240 Alcide, 2014, 172 Van der Heyden, 2014, 36 Eriksen, 2013, Norwegian physicians’ knowledge of the prices of pharmaceuticals: a survey, PLoS ONE, 8, e75218, 10.1371/journal.pone.0075218 Allan, 2007, Physician awareness of drug cost: a systematic review, PLoS Medicine, 4, e283, 10.1371/journal.pmed.0040283 Fraeyman, 2013, Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders, Journal de Pharmacie de Belgique, 18 Prosser, 2005, A qualitative study of GP's and PCO stakeholders’ views on the importance and influence of cost on prescribing, Social Science and Medicine, 60, 1335, 10.1016/j.socscimed.2004.07.013 Kasje, 2002, Dutch GPs’ perceptions: the influence of out-of-pocket costs on prescribing, Social Science and Medicine, 55, 1571, 10.1016/S0277-9536(01)00291-X Watkins, 2003, Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey, Quality and Safety in Health Care, 12, 29, 10.1136/qhc.12.1.29 Suhrcke, 2012, Will the recession be bad for our health? It depends, Social Science and Medicine, 74, 647, 10.1016/j.socscimed.2011.12.011 [Editorial], 2014, Health in austerity: hard decisions for hard times, The Lancet, 383, 9918 Ivankova, 2006, Using mixed-methods sequential explanatory design: from theory to practice, Field Methods, 18, 3, 10.1177/1525822X05282260 Fraeyman, 2012, Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in Belgium, Acta Clinica Belgica, 67, 160 Charmaz, 2006, 208 Vermeylen, 2013 Boeije, 2012 King, 2010 Alexander, 2003, Patient–physician communication about out-of-pocket costs, Journal of the American Medical Association, 290, 953, 10.1001/jama.290.7.953 Bryman, 2004, 592 Pound, 2005, Resisting medicines: a synthesis of qualitative studies of medicine taking, Social Science and Medicine, 61, 133, 10.1016/j.socscimed.2004.11.063 Wagner, 2008, Prescription drug co-payments and cost-related medication underuse, Health Economics, Policy and Law, 3, 51, 10.1017/S1744133107004380 Donovan, 1992, Patient non-compliance: deviance or reasoned decision-making?, Social Science and Medicine, 34, 507, 10.1016/0277-9536(92)90206-6 Vermeire, 2001, Patient adherence to treatment: three decades of research. A comprehensive review, Journal of Clinical Pharmacy and Therapeutics, 26, 331, 10.1046/j.1365-2710.2001.00363.x Gafni, 1998, The physician-patient encounter: the physician as a perfect agent for the patient versus the informed treatment decision-making model, Social Science and Medicine, 47, 347, 10.1016/S0277-9536(98)00091-4 Strech, 2014, How can bedside rationing be justified despite coexisting inefficiency? The need for ‘benchmarks of efficiency’, Journal of Medical Ethics, 40, 89, 10.1136/medethics-2012-100769 Pollock, 2000, Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource, Social Science and Medicine, 51, 1827, 10.1016/S0277-9536(00)00114-3 2011, 9 Weinstein, 2001, Should physicians be gatekeepers of medical resources?, Journal of Medical Ethics, 27, 268, 10.1136/jme.27.4.268 Voigt, 2014, Rationing, inefficiency and the role of clinicians, Journal of Medical Ethics, 40, 94, 10.1136/medethics-2012-101236 Drummond, 2011, Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?, The European Journal of Health Economics, 13, 1, 10.1007/s10198-011-0353-8 Luyten, 2013, 1